LI JUNJIE ＬＩＪＵＮＪＩＥ

Researcher Number	80869892
Other IDs	https://orcid.org/0000-0002-4862-2517
Affiliation (Current)	2023: 九州大学, 先導物質化学研究所, 准教授
Affiliation (based on the past Project Information) *help	2023: 九州大学, 先導物質化学研究所, 准教授 2020 – 2021: 公益財団法人川崎市産業振興財団(ナノ医療イノベーションセンター), ナノ医療イノベーションセンター, 研究員
Review Section/Research Field	Principal Investigator Basic Section 90120:Biomaterials-related
Keywords	Principal Investigator immunotherapy / nanoreactors / pyroptosis / self-assembly / vesicles / tumor metabolism / vesicle / nanoreactor / drug delivery

Development of Reversible Double-Layer Polymer Modification Technology to Break the Safety/Efficacy Trade-Off of Delivering EnzymePrincipal Investigator
- Principal Investigator
  
  LI JUNJIE
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 90120:Biomaterials-related
- Research Institution
  Kyushu University
Therapeutic polymer nanoreactor with site-specific activation of targeting Warburg metabolism for metastatic breast cancer treatmentPrincipal Investigator
- Principal Investigator
  
  LI JUNJIE
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 90120:Biomaterials-related
- Research Institution
  Kawasaki Institute of Industrial Promotion Innovation Center of NanoMedicine

All 2022 2021 2020

All Journal Article

[Journal Article] Effective mRNA Protection by Poly( <scp>l</scp> ‐ornithine) Synergizes with Endosomal Escape Functionality of a Charge‐Conversion Polymer toward Maximizing mRNA Introduction Efficiency2022
- Author(s)
  A. Dirisala, S. Uchida, J. Li, J.F.R. Van Guyse, K. Hayashi, S.V.C. Vummaleti, S. Kaur, Y. Mochida, S. Fukushima, K. Kataoka
- Journal Title
  
  Macromolecular Rapid Communications
  
  Volume: - Pages: 2100754-2100754
- DOI
  10.1002/marc.202100754
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21H04962, KAKENHI-PROJECT-21K19923, KAKENHI-PROJECT-20K20209, KAKENHI-PROJECT-21K18062
[Journal Article] Targeted nanomedicine in cisplatin-based cancer therapeutics2022
- Author(s)
  Han Yu、Wen Panyue、Li Junjie、Kataoka Kazunori
- Journal Title
  
  Journal of Controlled Release
  
  Volume: 345 Pages: 709-720
- DOI
  10.1016/j.jconrel.2022.03.049
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K20209
[Journal Article] Tumor-dilated polymersome nanofactories for enhanced enzyme prodrug chemo-immunotherapy2021
- Author(s)
  Japir Abd Al-Wali Mohammed M.、Ke Wendong、Li Junjie、Mukerabigwi Jean Felix、Ibrahim Alhadi、Wang Yuheng、Li Xiang、Zhou Qinghao、Mohammed Fathelrahman、Ge Zhishen
- Journal Title
  
  Journal of Controlled Release
  
  Volume: 339 Pages: 418-429
- DOI
  10.1016/j.jconrel.2021.10.015
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K20209
[Journal Article] Enzymatically Transformable Polymersome‐Based Nanotherapeutics to Eliminate Minimal Relapsable Cancer2021
- Author(s)
  J. Li, Z. Ge, K. Toh, X. Liu, A. Dirisala, W. Ke, P. Wen, H. Zhou, Z. Wang, S. Xiao, J.F.R. Van Guyse, T.A. Tockary, J. Xie, D. Gonzalez-Carter, H. Kinoh, S. Uchida, Y. Anraku, K. Kataoka
- Journal Title
  
  Advanced Materials
  
  Volume: 33 Pages: 2105254-2105254
- DOI
  10.1002/adma.202105254
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21H04962, KAKENHI-PROJECT-21K19923, KAKENHI-PROJECT-20K20209, KAKENHI-PROJECT-21K18062
[Journal Article] Hypoxia-responsive block copolymer polyprodrugs for complementary photodynamic-chemotherapy2021
- Author(s)
  Zhou Qinghao、Mohammed Fathelrahman、Wang Yuheng、Wang Jingbo、Lu Nannan、Li Junjie、Ge Zhishen
- Journal Title
  
  Journal of Controlled Release
  
  Volume: 339 Pages: 130-142
- DOI
  10.1016/j.jconrel.2021.09.023
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K20209
[Journal Article] Self‐Boosting Catalytic Nanoreactors Integrated with Triggerable Crosslinking Membrane Networks for Initiation of Immunogenic Cell Death by Pyroptosis2020
- Author(s)
  Junjie Li, Yasutaka Anraku, Kazunori Kataoka
- Journal Title
  
  Angewandte Chemie International Edition
  
  Volume: - Pages: 13526-13530
- DOI
  10.1002/anie.202004180
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17F17356, KAKENHI-PROJECT-20K20209
[Journal Article] Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation2020
- Author(s)
  Li Junjie、Kataoka Kazunori
- Journal Title
  
  Journal of the American Chemical Society
  
  Volume: 143 Pages: 538-559
- DOI
  10.1021/jacs.0c09029
- Data Source
  KAKENHI-PROJECT-20K20209

1. 内田智士

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
2. ディリサラアンジャネユル

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
3. 片岡一則

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

LI JUNJIE ＬＩ ＪＵＮＪＩＥ

Research Projects

Research Products

Co-Researchers

Development of Reversible Double-Layer Polymer Modification Technology to Break the Safety/Efficacy Trade-Off of Delivering EnzymePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Therapeutic polymer nanoreactor with site-specific activation of targeting Warburg metabolism for metastatic breast cancer treatmentPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Effective mRNA Protection by Poly( <scp>l</scp> ‐ornithine) Synergizes with Endosomal Escape Functionality of a Charge‐Conversion Polymer toward Maximizing mRNA Introduction Efficiency2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Targeted nanomedicine in cisplatin-based cancer therapeutics2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Tumor-dilated polymersome nanofactories for enhanced enzyme prodrug chemo-immunotherapy2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Enzymatically Transformable Polymersome‐Based Nanotherapeutics to Eliminate Minimal Relapsable Cancer2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Hypoxia-responsive block copolymer polyprodrugs for complementary photodynamic-chemotherapy2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Self‐Boosting Catalytic Nanoreactors Integrated with Triggerable Crosslinking Membrane Networks for Initiation of Immunogenic Cell Death by Pyroptosis2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation2020

Author(s)

Journal Title

DOI

Data Source

LI JUNJIE ＬＩＪＵＮＪＩＥ